Our client is a leading player in veterinary medicine. With growing demand for its innovative products, the company needed to more than double production of antigens and vaccines at an existing site. The challenge was to achieve this increase at a site in a residential location where there was no possibility of extension.
Royal HaskoningDHV was contracted to develop a masterplan and integrated design incorporating disciplines including structural engineering, architecture, MEP, infrastructure and fire safety. We then worked with the EPCM partner, FESP, to provide engineering expertise and design reviews through to handover.
By reviewing existing flows and ways of working, site activities were optimised as part of the process.
Space constraints were not the only challenge in upgrading the facility. Disturbance to production was minimised as a result of careful planning of the construction sequence. Office functions were moved offsite during the project and the new office building designed to meet LEED Silver certification. Care was taken to ensure effective communication with stakeholders, including local homes and businesses, throughout the process.
The upgraded facility provides the increased production capacity demands, while meeting all relevant legislative and environmental requirements.